<DOC>
	<DOCNO>NCT01153399</DOCNO>
	<brief_summary>The primary objective study collect epidemiological data EGFR mutation status [ M+ ( mutation positive ) , M- ( mutation negative ) ] population predominantly Caucasian ethnicity , correlate EGFR mutation status clinico-pathological characteristic ( e.g . smoking status , sex , histology , etc ) . In particular , study aim determine frequency EGFR M+ lung cancer patient clinico-pathological characteristic commonly associate EGFR mutation positivity ( i.e. , smoker , men , non-adenocarcinoma ) .</brief_summary>
	<brief_title>A Non-interventional Study ( NIS ) Registry Epidemiological Scientific Evaluation Epidermal Growth Factor Receptor ( EGFR ) Mutation Status Patients With Newly Diagnosed Locally Advanced Metastatic Non Small Cell Lung Cancer ( NSCLC ) ( Stage IIIB/IV Non-small Cell Lung Cancer ) .</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Signed write informed consent . 2 . Female male age 18 year . 3 . Histologically confirm locally advanced metastatic NSCLC ( stage IIIB/IV ) . 4 . Patients receive 1stline treatment IIIB/IV NSCLC . 5 . Patients know EGFR mutation status ( i.e . patient must either EGFR M+ , EGFR M EGFR Mx ) . 6 . Tumour amenable curative surgery radiotherapy . 1 . Mixed histology small cell nonsmall cell lung cancer .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>EGFR mutation</keyword>
</DOC>